Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Price Target at $610.19

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned an average recommendation of “Moderate Buy” from the twenty-one analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $611.86.

A number of analysts have recently weighed in on ISRG shares. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Howard Capital Management Group LLC increased its holdings in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. increased its stake in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after acquiring an additional 9,194 shares during the period. Empowered Funds LLC increased its stake in Intuitive Surgical by 4.4% during the third quarter. Empowered Funds LLC now owns 8,177 shares of the medical equipment provider’s stock valued at $4,017,000 after acquiring an additional 345 shares during the period. Atlanta Consulting Group Advisors LLC acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $505,000. Finally, Claro Advisors LLC lifted its position in shares of Intuitive Surgical by 34.3% in the 3rd quarter. Claro Advisors LLC now owns 1,213 shares of the medical equipment provider’s stock worth $596,000 after acquiring an additional 310 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $492.49 on Tuesday. Intuitive Surgical has a one year low of $364.17 and a one year high of $616.00. The company has a 50-day simple moving average of $562.24 and a 200-day simple moving average of $531.67. The firm has a market capitalization of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.